Title |
Chemotherapy-induced Dkk-1 expression by primary human mesenchymal stem cells is p53 dependent
|
---|---|
Published in |
Medical Oncology, September 2016
|
DOI | 10.1007/s12032-016-0826-9 |
Pubmed ID | |
Authors |
Ian Hare, Rebecca Evans, James Fortney, Blake Moses, Debbie Piktel, William Slone, Laura F. Gibson |
Abstract |
Mesenchymal stem cells (MSCs) are abundant throughout the body and regulate signaling within tumor microenvironments. Wnt signaling is an extrinsically regulated pathway that has been shown to regulate tumorigenesis in many types of cancer. After evaluating a panel of Wnt activating and inhibiting molecules, we show that primary human MSCs increase the expression of Dkk-1, an inhibitor of Wnt signaling, into the extracellular environment following chemotherapy exposure in a p53-dependent manner. Dkk-1 has been shown to promote tumor growth in several models of malignancy, suggesting that MSC-derived Dkk-1 could counteract the intent of cytotoxic chemotherapy, and that pharmacologic inhibition of Dkk-1 in patients receiving chemotherapy treatment for certain malignancies may be warranted. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 14% |
Unknown | 6 | 86% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 3 | 43% |
Other | 2 | 29% |
Student > Doctoral Student | 2 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 43% |
Nursing and Health Professions | 1 | 14% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 14% |
Agricultural and Biological Sciences | 1 | 14% |
Engineering | 1 | 14% |
Other | 0 | 0% |